Twin Securities’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-82,300
Closed -$14.6M 15
2020
Q1
$14.6M Buy
+82,300
New +$15.5M 7.46% 2
2017
Q1
Sell
-70,000
Closed -$14.7M 26
2016
Q4
$14.7M Buy
+70,000
New +$14.5M 2.41% 9
2016
Q3
Sell
-150,000
Closed -$34.7M 30
2016
Q2
$34.7M Buy
+150,000
New +$34.6M 6.26% 8
2015
Q2
Sell
-65,000
Closed -$19.3M 32
2015
Q1
$19.3M Buy
65,000
+60,000
+1,200% +$17.1M 2.27% 10
2014
Q4
$1.29M Buy
+5,000
New +$1.25M 0.23% 13

Other funds holding AGN

Twin Securities's AGN Position: Q2 2020 in Review

Twin Securities sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 667,224 shares — an estimated $118M sold.

Twin Securities first reported a position in AGN in Q3 2014 and held it in 13 quarters. The position peaked at $118M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Twin Securities reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Twin Securities sold 667,224 Allergan plc shares in Q2 2020, an estimated $118M.
  • Twin Securities first reported a position in Allergan plc in Q3 2014 and held it in 13 quarters.
  • Twin Securities's Allergan plc position peaked at $118M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Twin Securities's 13F filing for Q2 2020, filed 14 Aug 2020.